10.3 Tissue proteomics and imaging mass spectrometry

Tissue proteomics and imaging mass spectrometry are powerful tools for analyzing proteins in specific tissues. These techniques reveal molecular composition and function, offering insights into disease pathology and drug distribution.

From cancer research to neurodegenerative diseases, these methods have wide-ranging clinical applications. They help delineate tumor margins, identify biomarkers, and map protein aggregates in brain tissue, advancing our understanding of complex diseases and guiding treatment strategies.

Principles and Applications of Tissue Proteomics and Imaging Mass Spectrometry

Principles of tissue proteomics

Top images from around the web for Principles of tissue proteomics

• 

  Data-independent acquisition mass spectrometry (DIA-MS) for proteomic applications in oncology ... View original

  Is this image relevant?

• 

  Frontiers | Illuminating Spatial and Temporal Organization of Protein Interaction Networks by ... View original

  Is this image relevant?

• 

  Proteomics/Protein Sample Preparation/Sample Preparation for Mass Spectrometry - Wikibooks, open ... View original

  Is this image relevant?

• 

  Data-independent acquisition mass spectrometry (DIA-MS) for proteomic applications in oncology ... View original

  Is this image relevant?

• 

  Frontiers | Illuminating Spatial and Temporal Organization of Protein Interaction Networks by ... View original

  Is this image relevant?

1 of 3

Top images from around the web for Principles of tissue proteomics

• 

  Data-independent acquisition mass spectrometry (DIA-MS) for proteomic applications in oncology ... View original

  Is this image relevant?

• 

  Frontiers | Illuminating Spatial and Temporal Organization of Protein Interaction Networks by ... View original

  Is this image relevant?

• 

  Proteomics/Protein Sample Preparation/Sample Preparation for Mass Spectrometry - Wikibooks, open ... View original

  Is this image relevant?

• 

  Data-independent acquisition mass spectrometry (DIA-MS) for proteomic applications in oncology ... View original

  Is this image relevant?

• 

  Frontiers | Illuminating Spatial and Temporal Organization of Protein Interaction Networks by ... View original

  Is this image relevant?

1 of 3

• Tissue proteomics analyzes protein content in specific tissue samples revealing molecular composition and function
• Sample preparation methods crucial for accurate analysis
  • Tissue homogenization breaks down tissue structure releasing proteins
  • Protein extraction isolates proteins from cellular debris (detergents, sonication)
  • Enzymatic digestion cleaves proteins into peptides for mass spectrometry analysis (trypsin)
• Imaging mass spectrometry (IMS) directly analyzes tissue sections preserving spatial information
  • Spatial distribution of molecules mapped across tissue surface
  • Techniques utilize different ionization methods
    1. Matrix-assisted laser desorption/ionization (MALDI) uses laser to ionize matrix-coated tissue
    2. Desorption electrospray ionization (DESI) applies charged solvent spray to tissue surface
    3. Secondary ion mass spectrometry (SIMS) bombards surface with primary ion beam
• Mass analyzers in IMS separate ions based on mass-to-charge ratio
  • Time-of-flight (TOF) measures ion flight time
  • Fourier transform ion cyclotron resonance (FT-ICR) uses cyclotron frequency in magnetic field
  • Orbitrap employs ion oscillation around central electrode

Spatial resolution in mass spectrometry

• Spatial resolution typically ranges from 10-200 μm determining level of detail in molecular images
• Factors affecting resolution impact image quality and information content
  • Laser spot size in MALDI influences pixel size
  • Ion beam focus in SIMS determines sampling area
  • Sample preparation quality affects signal intensity and reproducibility
• Molecular information obtained varies based on technique and sample type
  • Detection of biomolecules provides insights into tissue composition (proteins, lipids, metabolites)
  • Mass range differs for various compound classes
    • Low molecular weight compounds detected below 1000 Da (amino acids, small metabolites)
    • Proteins analyzed up to 100 kDa (enzymes, receptors)
• Data visualization techniques aid in interpretation and analysis
  • Heat maps display intensity of specific molecules across tissue section
  • 3D molecular images combine multiple tissue sections for volumetric representation

Clinical Applications and Case Studies

Applications for disease pathology

• Cancer research utilizes IMS for various aspects of tumor biology
  • Tumor margin delineation aids surgical planning and resection
  • Identification of cancer-specific biomarkers improves diagnosis and prognosis
  • Characterization of tumor microenvironment reveals interactions between cancer and stromal cells
• Neurodegenerative diseases benefit from spatial analysis of protein aggregates
  • Mapping of protein aggregates in brain tissue localizes disease-associated proteins (amyloid-β, tau)
  • Analysis of lipid changes in Alzheimer's disease identifies altered membrane composition
• Cardiovascular diseases studied through tissue composition analysis
  • Atherosclerotic plaque composition analysis reveals vulnerable plaque characteristics
  • Myocardial infarction studies map changes in protein and metabolite distribution
• Drug distribution studies provide insights into pharmacology
  • Pharmacokinetics and pharmacodynamics visualized in tissue context
  • Drug metabolism in different tissue types informs dosing and toxicity
• Tissue heterogeneity analysis uncovers molecular complexity
  • Identification of distinct molecular regions within tissues reveals functional differences
  • Correlation of molecular profiles with histological features links structure to function

Case studies in clinical research

• Breast cancer heterogeneity study revealed therapy-resistant areas through IMS
  • Distinct molecular profiles identified within tumor regions
  • Guided personalized treatment strategies based on molecular subtypes
• Alzheimer's disease brain mapping correlated protein distribution with disease progression
  • Spatial distribution of amyloid-β and tau proteins mapped across brain regions
  • Cognitive decline progression linked to specific protein accumulation patterns
• Kidney transplant rejection analysis improved patient monitoring
  • Tissue proteomics identified novel biomarkers for early rejection
  • Enhanced treatment strategies developed based on molecular signatures
• Drug penetration in solid tumors visualized barriers to effective delivery
  • IMS images of drug distribution in tumor sections revealed heterogeneous uptake
  • Insights gained informed drug delivery optimization strategies
• Multiple sclerosis lesion characterization uncovered potential therapeutic targets
  • Protein and lipid changes mapped in demyelinated areas
  • Identified molecular targets for remyelination therapies